The biotechnology company intends to more than double its current production capacity at the Navy Yard, interim CEO Fred Vogt ...

Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with ...

Use of nivolumab (Opdivo) before chemotherapy was not associated with improved pathologic complete response (pCR) rates among ...

Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.

Objectives To explore the relationship between the pretreatment or post-treatment neutrophil to lymphocyte ratio (NLR) and overall survival (OS)/progression-free survival (PFS) in patients with lung ...

BACKGROUND: Despite the high morbidity and mortality of heart failure with preserved ejection fraction (HFpEF), treatment ...

European Commission approves Bristol Myers Squibb’s Opdivo plus Yervoy for first-line treatment of adult patients with unresectable or advanced HCC: Princeton, New Jersey Monday ...

【引用本文】柳宗翰，江 宇，裴梦淼，等. 三级淋巴结构与肝癌预后及治疗疗效关系研究进展[J].

People with disabilities (PwD) are more likely to report negative experiences with the cultural responsiveness of health care providers (HCPs). HealthDay News — People with disabilities (PwD) are more ...